NCT05975177 (SFYCT) is a NA clinical trial of Sterify Gel in Parodontitis, sponsored by Sterify S.r.l..

Who is sponsoring NCT05975177?

NCT05975177 is sponsored by Sterify S.r.l..

What drugs are being tested in NCT05975177?

Interventions in NCT05975177: Sterify Gel, Scaling and root planing.

What condition does NCT05975177 study?

NCT05975177 studies Parodontitis.

Is NCT05975177 still recruiting?

NCT05975177 is currently completed. Last updated 7 August 2023.

Last reviewed 2023-08-07 · How we verify

NCT05975177: SFYCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Efficacy of STERIFY GEL in the Treatment of Periodontitis Following Scaling and Root Planing

Completed NA Last updated 7 August 2023

What this trial tests

NA trial testing Sterify Gel in Parodontitis in 34 participants. Completed in 6 April 2023.

Timeline

3 December 2022

Primary endpoint
11 March 2023

6 April 2023

Quick facts

Lead sponsor	Sterify S.r.l.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	34
Start date	3 December 2022
Primary completion	11 March 2023
Estimated completion	6 April 2023
Sites	1 location across Italy

Drugs / interventions tested

Sterify Gel
Scaling and root planing

Conditions studied

Parodontitis — all drugs for Parodontitis →

Sponsor

Sterify S.r.l.

Who can join

18 and older, any sex, with Parodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical study is to evaluate the safety and efficacy of treating periodontal disease with the STERIFY GEL medical device in combination with SRP procedure, in terms of periodontal pocket healing. Efficacy will be compared with the use of the nonsurgical SRP technique alone, which is considered a gold standard treatment for periodontitis, with the aim of observing improved results when using the STERIFY GEL device. The study is prospective, split-mouth.STERIFY GEL will be administered into the periodontal pockets of one or two segments of patients undergoing whole-mouth extended SRP, with the contralateral segments serving as controls (split-mouth), in a single session.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Parodontitis

Currently open trials in the same condition.

NCT06576622 — PERIodontal Disease, Microbiota and Miscarriage · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05975177 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sterify S.r.l.
Last refreshed: 7 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05975177.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing